These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 27742814)

  • 1. Progression of brain atrophy in PSP and CBS over 6 months and 1 year.
    Dutt S; Binney RJ; Heuer HW; Luong P; Attygalle S; Bhatt P; Marx GA; Elofson J; Tartaglia MC; Litvan I; McGinnis SM; Dickerson BC; Kornak J; Waltzman D; Voltarelli L; Schuff N; Rabinovici GD; Kramer JH; Jack CR; Miller BL; Rosen HJ; Boxer AL;
    Neurology; 2016 Nov; 87(19):2016-2025. PubMed ID: 27742814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration.
    Santos-Santos MA; Mandelli ML; Binney RJ; Ogar J; Wilson SM; Henry ML; Hubbard HI; Meese M; Attygalle S; Rosenberg L; Pakvasa M; Trojanowski JQ; Grinberg LT; Rosen H; Boxer AL; Miller BL; Seeley WW; Gorno-Tempini ML
    JAMA Neurol; 2016 Jun; 73(6):733-42. PubMed ID: 27111692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of Microstructural Degeneration in Progressive Supranuclear Palsy and Corticobasal Syndrome: A Longitudinal Diffusion Tensor Imaging Study.
    Zhang Y; Walter R; Ng P; Luong PN; Dutt S; Heuer H; Rojas-Rodriguez JC; Tsai R; Litvan I; Dickerson BC; Tartaglia MC; Rabinovici G; Miller BL; Rosen HJ; Schuff N; Boxer AL
    PLoS One; 2016; 11(6):e0157218. PubMed ID: 27310132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants.
    Whitwell JL; Tosakulwong N; Botha H; Ali F; Clark HM; Duffy JR; Utianski RL; Stevens CA; Weigand SD; Schwarz CG; Senjem ML; Jack CR; Lowe VJ; Ahlskog JE; Dickson DW; Josephs KA
    Neuroimage Clin; 2020; 25():102152. PubMed ID: 31935638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy.
    Boxer AL; Geschwind MD; Belfor N; Gorno-Tempini ML; Schauer GF; Miller BL; Weiner MW; Rosen HJ
    Arch Neurol; 2006 Jan; 63(1):81-6. PubMed ID: 16401739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Accuracy of Magnetic Resonance Imaging Measures of Brain Atrophy Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Degeneration.
    Illán-Gala I; Nigro S; VandeVrede L; Falgàs N; Heuer HW; Painous C; Compta Y; Martí MJ; Montal V; Pagonabarraga J; Kulisevsky J; Lleó A; Fortea J; Logroscino G; Quattrone A; Quattrone A; Perry DC; Gorno-Tempini ML; Rosen HJ; Grinberg LT; Spina S; La Joie R; Rabinovici GD; Miller BL; Rojas JC; Seeley WW; Boxer AL
    JAMA Netw Open; 2022 Apr; 5(4):e229588. PubMed ID: 35486397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging correlates of pathology in corticobasal syndrome.
    Whitwell JL; Jack CR; Boeve BF; Parisi JE; Ahlskog JE; Drubach DA; Senjem ML; Knopman DS; Petersen RC; Dickson DW; Josephs KA
    Neurology; 2010 Nov; 75(21):1879-87. PubMed ID: 21098403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the Effect of Alzheimer's Disease-Related Biomarker Change in Corticobasal Syndrome and Progressive Supranuclear Palsy.
    Garcia-Cordero I; Anastassiadis C; Khoja A; Morales-Rivero A; Thapa S; Vasilevskaya A; Davenport C; Sumra V; Couto B; Multani N; Taghdiri F; Anor C; Misquitta K; Vandevrede L; Heuer H; Tang-Wai D; Dickerson B; Pantelyat A; Litvan I; Boeve B; Rojas JC; Ljubenkov P; Huey E; Fox S; Kovacs GG; Boxer A; Lang A; Tartaglia MC;
    Ann Neurol; 2024 Jul; 96(1):99-109. PubMed ID: 38578117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant.
    Ling H; de Silva R; Massey LA; Courtney R; Hondhamuni G; Bajaj N; Lowe J; Holton JL; Lees A; Revesz T
    Neuropathol Appl Neurobiol; 2014 Feb; 40(2):149-63. PubMed ID: 23432126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration.
    Gröschel K; Hauser TK; Luft A; Patronas N; Dichgans J; Litvan I; Schulz JB
    Neuroimage; 2004 Feb; 21(2):714-24. PubMed ID: 14980574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voxel-based morphometry in autopsy proven PSP and CBD.
    Josephs KA; Whitwell JL; Dickson DW; Boeve BF; Knopman DS; Petersen RC; Parisi JE; Jack CR
    Neurobiol Aging; 2008 Feb; 29(2):280-9. PubMed ID: 17097770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A follow-up study on brainstem atrophy in progressive supranuclear palsy--when does brain MRI contribute to the differential diagnosis between progressive supranuclear palsy and Parkinson disease?].
    Yamamoto T; Oya Y; Ogawa M; Ogata K; Kawai M
    Rinsho Shinkeigaku; 2003 Jul; 43(7):392-7. PubMed ID: 14582364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical correlates of longitudinal brain atrophy in progressive supranuclear palsy.
    Tsai RM; Lobach I; Bang J; Whitwell JL; Senjem ML; Jack CR; Rosen H; Miller B; Boxer AL;
    Parkinsonism Relat Disord; 2016 Jul; 28():29-35. PubMed ID: 27132501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrophy in midbrain & cerebral/cerebellar pedunculi is characteristic for progressive supranuclear palsy - A double-validation whole-brain meta-analysis.
    Albrecht F; Bisenius S; Neumann J; Whitwell J; Schroeter ML
    Neuroimage Clin; 2019; 22():101722. PubMed ID: 30831462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR imaging of brainstem atrophy in progressive supranuclear palsy.
    Slowinski J; Imamura A; Uitti RJ; Pooley RA; Strongosky AJ; Dickson DW; Broderick DF; Wszolek ZK
    J Neurol; 2008 Jan; 255(1):37-44. PubMed ID: 18080856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson's syndrome.
    Sakurai K; Imabayashi E; Tokumaru AM; Hasebe S; Murayama S; Morimoto S; Kanemaru K; Takao M; Shibamoto Y; Matsukawa N
    Neuroimage Clin; 2015; 7():605-10. PubMed ID: 26082887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptomatology in 4-repeat tauopathies is associated with data-driven topology of [
    Schönecker S; Palleis C; Franzmeier N; Katzdobler S; Ferschmann C; Schuster S; Finze A; Scheifele M; Prix C; Fietzek U; Weidinger E; Nübling G; Vöglein J; Patt M; Barthel H; Sabri O; Danek A; Höglinger GU; Brendel M; Levin J;
    Neuroimage Clin; 2023; 38():103402. PubMed ID: 37087820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations.
    Paviour DC; Price SL; Jahanshahi M; Lees AJ; Fox NC
    Mov Disord; 2006 Jul; 21(7):989-96. PubMed ID: 16602104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Progression of Midbrain Atrophy in Parkinsonism: Longitudinal MRI Study.
    Hwang M; Yang H; Kim Y; Youn J; Park J; Huh YE; Kim HT; Cho JW
    Neurodegener Dis; 2017; 17(1):31-37. PubMed ID: 27614955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of Eye Movement Impairment Correlate with Regional Brain Atrophy in Neurodegenerative Parkinsonism.
    Vintonyak O; Gorges M; Müller HP; Pinkhardt EH; Ludolph AC; Huppertz HJ; Kassubek J
    Neurodegener Dis; 2017; 17(4-5):117-126. PubMed ID: 28268209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.